Page last updated: 2024-08-23

tobramycin and Acute Symptom Flare

tobramycin has been researched along with Acute Symptom Flare in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (33.33)	24.3611
2020's	2 (66.67)	2.80

Authors

Authors	Studies
Bilton, D; Cipolli, M; Clancy, JP; Eagle, G; Fajac, I; Galeva, I; Gupta, R; Konstan, MW; Liu, K; McGinnis, JP; Minic, P; Pressler, T; Quittner, AL; Sands, D; Solé, A	1
Dorgan, D; Fifer, RC; Flume, PA; Harruff, EE; Jain, R; Kil, J; Kim, YJM; Ortiz, MGT; Poth, EA; Shoup, AG	1
Deka, R; Hong, LT; King, JB; Liou, TG; Stevens, V; Young, DC	1

Trials

1 trial(s) available for tobramycin and Acute Symptom Flare

Article	Year
Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2020, Volume: 19, Issue:2 Topics: Administration, Inhalation; Adult; Amikacin; Anti-Bacterial Agents; Cystic Fibrosis; Dose-Response Relationship, Drug; Female; Hospitalization; Humans; Liposomes; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Function Tests; Sputum; Surveys and Questionnaires; Symptom Assessment; Symptom Flare Up; Tobramycin; Treatment Outcome	2020

Article

Year

Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2020, Volume: 19, Issue:2

Topics: Administration, Inhalation; Adult; Amikacin; Anti-Bacterial Agents; Cystic Fibrosis; Dose-Response Relationship, Drug; Female; Hospitalization; Humans; Liposomes; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Function Tests; Sputum; Surveys and Questionnaires; Symptom Assessment; Symptom Flare Up; Tobramycin; Treatment Outcome

2020

Other Studies

2 other study(ies) available for tobramycin and Acute Symptom Flare

Article	Year
Ototoxicity in cystic fibrosis patients receiving intravenous tobramycin for acute pulmonary exacerbation: Ototoxicity following tobramycin treatment. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2021, Volume: 20, Issue:2 Topics: Administration, Intravenous; Adolescent; Adult; Aminoglycosides; Audiometry, Pure-Tone; Cystic Fibrosis; Female; Hearing Loss; Humans; Male; Middle Aged; Ototoxicity; Respiratory Tract Infections; Symptom Flare Up; Tobramycin	2021
Pharmacokinetics of Continuous Infusion Beta-lactams in the Treatment of Acute Pulmonary Exacerbations in Adult Patients With Cystic Fibrosis. Chest, 2018, Volume: 154, Issue:5 Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Cystic Fibrosis; Disease Progression; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Retrospective Studies; Symptom Flare Up; Tobramycin	2018

Article

Year

Ototoxicity in cystic fibrosis patients receiving intravenous tobramycin for acute pulmonary exacerbation: Ototoxicity following tobramycin treatment.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2021, Volume: 20, Issue:2

Topics: Administration, Intravenous; Adolescent; Adult; Aminoglycosides; Audiometry, Pure-Tone; Cystic Fibrosis; Female; Hearing Loss; Humans; Male; Middle Aged; Ototoxicity; Respiratory Tract Infections; Symptom Flare Up; Tobramycin

2021

Pharmacokinetics of Continuous Infusion Beta-lactams in the Treatment of Acute Pulmonary Exacerbations in Adult Patients With Cystic Fibrosis.

Chest, 2018, Volume: 154, Issue:5

Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Cystic Fibrosis; Disease Progression; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Retrospective Studies; Symptom Flare Up; Tobramycin

2018